Mycobacterium porcinum Skin and Soft Tissue Infections After Vaccinations — Indiana, Kentucky, and Ohio, September 2018–February 2019

• DOI: 10.15585/mmwr.mm7042a3
• Publication Date: 2021-10-21T16:13:04Z
• Authors: Erin F. Blau; Andrea Flinchum; Kathryn L. Gaub; Kathleen P. Hartnett; Michael Curran; Virginia K. Allen; Allison Napier; Elisabeth M. Hesse; Anne M. Hause; Rachel Cathey; Christine Feaster; Marika Mohr; Sietske de Fijter; Sarah Mitchell; Heather A. Moulto...; Isaac Benowitz; Kevin B. Spicer; Douglas A. Thorou...
• Keywords: Adult; Male; Indiana; Soft Tissue Infections; Vaccination; Kentucky; Skin Diseases, Bacterial; Middle Aged; 3. Good health; Young Adult; 03 medical and health sciences; 0302 clinical medicine; Humans; Female; Full Report; Mycobacteriaceae; Aged; Ohio

During December 2018-February 2019, a multistate investigation identified 101 patients with vaccination-associated adverse events among an estimated 940 persons in Kentucky, Indiana, and Ohio who had received influenza; hepatitis A; pneumococcal; or tetanus toxoid, reduced diphtheria acellular pertussis (Tdap) vaccines at the workplace during September 11-November 28, 2018. These been administered by staff members of third-party health care company contracted 24 businesses. Company A provided multiple vaccine types vaccination across 54 locations these adjoining states. Injection-site wound isolates from yielded Mycobacterium porcinum, nontuberculous mycobacteria (NTM) species fortuitum group; subtyping using pulsed-field gel electrophoresis all 28 available two closely related clusters. Site visits to interviews inadequate hand hygiene, improper storage handling, lack appropriate medical record documentation, reporting Vaccine Adverse Event Reporting System (VAERS). Vaccination-associated can be prevented training workers responsible for handling administering safe administration, practices, timely any suspected VAERS, notifying public authorities event